Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

The immune checkpoint inhibitors ipilimumab, nivolumab, and pembrolizumab represent a substantial improvement in treating advanced melanoma but are associated with adverse events (AEs) likely related to general immunologic enhancement. To ensure that patients receive optimal benefit from these agent...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Adv Pract Oncol
Hoofdauteurs: Weinstein, Alyona, Gordon, Ruth-Ann, Kasler, Mary Kate, Burke, Matthew, Ranjan, Smita, Hodgetts, Jackie, Reed, Vanessa, Shames, Yelena, Prempeh-Keteku, Nana, Lingard, Karla
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Harborside Press 2017
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995532/
https://ncbi.nlm.nih.gov/pubmed/29900017
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items